The Source on Healthcare Price & Competition’s mission is to provide up-to-date and easily accessible information about healthcare price and competition in the United States by posting news articles, policy papers, academic articles, litigation documents, and legislative/regulatory materials, as well as legal and policy-based analysis of those materials. Further, we aim to offer a diverse array of stakeholder perspectives on the problems associated with healthcare prices and markets, as well as potential solutions, to apprise our readers of the full scope of the existing debate. The Source aims not only to bridge the gaps between health policy, health services research, and legal experts working on these issues, but also to serve as a resource for journalists, state attorneys general, potential litigants, and others seeking to understand and/or promote cost control and competition in healthcare. Specifically, the Source focuses on market issues, such as provider leverage and reform efforts, including the promotion of price transparency in healthcare.
Although the Source is academically based and not aligned with any advocacy-based organizations or parties to litigation, it aims to serve as a catalyst for change within the U.S. healthcare system. It will operate as a core repository and central resource of materials that will empower individuals and groups seeking to bring rationality to healthcare markets. We at the Source believe that effective solutions to healthcare price and competition problems must be drawn from diverse disciplines including economics, health services research, medicine, and the law. We are pleased to provide a forum for this important discussion.
Jaime S. King is a Professor of Law at the University of California Hastings College of the Law. She is also the Associate Dean and Co-Faculty Director of the UCSF/UC Hastings Consortium on Science, Law and Health Policy, the Co-Founder and Co-Director of the UCSF/UC Hastings Masters in Health Law and Policy Program, and the Director of the Concentration on Law and Health Sciences. Professor King holds a Ph.D. in Health Policy from Harvard University, a J.D. from Emory University, and a B.A. from Dartmouth College.
Professor King’s research focuses on the drivers of healthcare costs, with a special interest in market consolidation and efforts to improve transparency in healthcare pricing. She is the Founder and Executive Editor of The Health Reform Tracker, a web-based resource for information and analysis about healthcare reform. In 2015, she testified before the House Judiciary Subcommittee on Regulatory Reform, Commercial, and Antitrust Law on issues surrounding health insurance mergers. Professor King is the 2015 recipient of the UC Hastings Foundation Faculty Award for Outstanding Scholarship.
Prior to joining the faculty at UC Hastings, she served as a Fellow at the Center for Law and the Biosciences at Stanford Law School (2006-2008) and the American Society of Law, Medicine, and Ethics (2005-2006). In 2012, she was named the John “Jack” Wennberg Fellow for the Informed Medical Decisions Foundation for her research on shared decision-making.
Amy Y. Gu, J.D., is the Managing Editor of The Source on Healthcare Price & Competition. She holds a J.D. from Loyola Law School and a B.A. in Economics from the University of California, Berkeley and brings to the Source a unique set of experience and perspective from both law and tech. As a licensed attorney, Amy practiced civil litigation and represented global pharmaceutical companies in FCPA compliance and discovery prior to joining The Source. She applies her legal expertise in her coverage and analysis of antitrust enforcement and healthcare litigation on The Source. Drawing upon her experience in co-founding an e-commerce platform, she further executes the mission of The Source in the design of the content and functionalities of the site to expand its scope and reach.
Katie Gudiksen, Ph.D., is a Senior Health Policy Researcher for The Source on Healthcare Price and Competition. She is a recent graduate of the UCSF/UC Hastings Master of Science in Health Policy and Law program, where she studied policy solutions to promote competition in the pharmaceutical industry. Prior to joining The Source, she co-founded a cancer diagnostics company and worked as Director of Technology where she worked to develop technologies to detect biomarker signatures for aggressive prostate cancer. She also holds an A.M. and Ph.D. in Chemistry from Harvard University and a B.S. and B.A. from Hope College.
Laura Hagen, J.D., is a Health Policy Researcher for the UCSF/UC Hastings Consortium. She is currently working on The State Laws Impacting Healthcare Cost and Quality (SLIHCQ) Database. Prior to joining The Source, she maintained the Health Reform Tracker, a project of the UCSF/UC Hastings Consortium that tracked national and California health care reform efforts under the first year of Donald Trump’s presidency. Laura attended the University of California, Hastings College of the Law, where she graduated with a concentration in law and health sciences. While at UC Hastings, Laura researched Food and Drug Administration regulations and their practical effects on the industry. Her work has been published in the American Bar Association’s The Health Lawyer and has been honored with the first place prize for the 18th Annual Epstein Becker Green Health Law Writing Competition.
Samuel “Sammy” Chang, J.D., is a Health Policy Researcher for The Source on Healthcare Price and Competition. He currently writes the monthly California Legislative Beat on the Source Blog. Prior to joining The Source, he served as the Student Caucus Chair for the Executive Oversight Board for the University of California, Student Health Insurance Plan and worked as a legal intern for the California Department of Managed Health Care’s Office of Legal Services. At UC Hastings, he received a CALI Award for Academic Excellence for his work on the Public Policy and Law Workgroup. He additionally contributed to the California Senate Committee on Business, Professions, and Economic Development background paper on pharmacy benefit managers. Sammy has been recognized by the American Bar Association and the UC Hastings Board of Directors for his vision and dedicated leadership and has testified in front of the California Assembly Judiciary Committee and the ABA Commission on the Future of Legal Education. Sammy is a recent graduate of UC Hastings College of the Law with a concentration in law and health sciences and holds a B.S. degree in Biochemistry/Cell Biology from UC San Diego.
Gary K. Ko, CFA is a Research Fellow for The Source on Healthcare Price and Competition. His current research focuses on price transparency and competition within the U.S. healthcare system, with emphasis on analysis in economic incentives of stakeholders. He is also President of California Medical Billing Advocates (www.calmba.org), a non-profit organization that aims to reduce or eliminate unjust medical bills before they become crippling debt. Prior to joining the source, he spent close to 19 years at Franklin Templeton Investments, where he was Vice President / Equity Research Analyst, and member of an investment team that managed up to $130 billion in assets. He has founded two for-profit companies during his career and is a CFA charterholder.
During Gary’s finance career, he specialized in analyzing healthcare equities, including publicly traded managed care organizations, healthcare supply chain (distributors, PBMs, pharmacies), hospitals and post acute facilities, mental health facilities, staffing companies, contract research organizations, contract development and manufacturing organizations, clinical laboratories, healthcare IT, and life sciences tools. He had also analyzed and valued numerous mid to late stage private healthcare companies. During his finance career, he observed first-hand how the profit maximizing motives from stakeholders often do not align with public interest, and got interested in finding ways to affect positive change in the U.S. healthcare system.